| J9271 | Injection, pembrolizumab, 1 mg | 6,600 | $40 | $290.4K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 4,860 | $40 | $189.5K |
| J0897 | Injection, denosumab, 1 mg | 4,920 | $20 | $88.6K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,350 | $40 | $47.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 470 | $80 | $39.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 200 | $100 | $21K |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 240 | $80 | $19.7K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 2,540 | $10 | $12.7K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 90 | $140 | $12.2K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 40 | $180 | $7.2K |